Cargando…
Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors
BACKGROUND: The Ras-dependent ERK1/2 MAP kinase signaling pathway plays a central role in cell proliferation control and is frequently activated in human colorectal cancer. Small-molecule inhibitors of MEK1/MEK2 are therefore viewed as attractive drug candidates for the targeted therapy of this mali...
Autores principales: | Voisin, Laure, Julien, Catherine, Duhamel, Stéphanie, Gopalbhai, Kailesh, Claveau, Isabelle, Saba-El-Leil, Marc K, Rodrigue-Gervais, Ian Gaël, Gaboury, Louis, Lamarre, Daniel, Basik, Mark, Meloche, Sylvain |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596176/ https://www.ncbi.nlm.nih.gov/pubmed/19014680 http://dx.doi.org/10.1186/1471-2407-8-337 |
Ejemplares similares
-
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
por: Frémin, Christophe, et al.
Publicado: (2010) -
Activation of MEK2 is sufficient to induce skin papilloma formation in transgenic zebrafish
por: Chou, Chih-Ming, et al.
Publicado: (2015) -
Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021) -
Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance
por: Greaves, Sarah A., et al.
Publicado: (2018) -
Corrigendum: Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance
por: Greaves, Sarah A., et al.
Publicado: (2018)